Parsey Merdad
Director | Chief Medical Officer
3 companies
Insider Signal Score
52
AverageTrades Analyzed
13
12M Win Rate
30.8%
Avg 3M Return
-2.4%
Avg 12M Return
-25.8%
Parsey Merdad is a Chief Medical Officer at GILEAD SCIENCES, INC. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 16 sells.
Estimated insider holdings value: $10.9M based on current market prices.
Holdings by Company
Transaction History
Showing 10 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 27, 2024 | GILD Gilead Sciences, Inc. | Chief Medical Officer | Sale+OE | 164,211 | $91.92 | $15,094,013.40 | -22.9% | +20.7% | +36.2% | |
| Nov 6, 2024 | GILD Gilead Sciences, Inc. | Chief Medical Officer | Sale+OE | 25,590 | $91.50 | $2,341,485.00 | -11.1% | +6.9% | +34.6% | |
| Oct 1, 2024 | GILD Gilead Sciences, Inc. | Chief Medical Officer | Sell | 2,000 | $83.83 | $167,660.00 | -2.0% | +9.6% | +32.4% | |
| Sep 12, 2024 | GILD Gilead Sciences, Inc. | Chief Medical Officer | Sale+OE | 21,246 | $84.50 | $1,795,287.00 | -17.2% | +11.1% | +37.7% | |
| Jul 1, 2024 | GILD Gilead Sciences, Inc. | Chief Medical Officer | Sell | 2,000 | $68.63 | $137,260.00 | -2.0% | +22.1% | +62.8% | |
| Apr 1, 2024 | GILD Gilead Sciences, Inc. | Chief Medical Officer | Sell | 2,000 | $72.96 | $145,920.00 | -2.0% | -5.8% | +52.7% | |
| Feb 29, 2024 | GILD Gilead Sciences, Inc. | Chief Medical Officer | Sell | 10,230 | $72.82 | $744,983.86 | -5.0% | -11.9% | +58.5% | |
| Sep 12, 2023 | GILD Gilead Sciences, Inc. | Chief Medical Officer | Sell | 1,501 | $76.99 | $115,561.99 | -2.1% | +4.3% | +5.4% | |
| Jun 13, 2023 | GILD Gilead Sciences, Inc. | Chief Medical Officer | Sell | 1,485 | $76.90 | $114,196.50 | -4.8% | -1.8% | -18.0% | |
| Mar 13, 2023 | GILD Gilead Sciences, Inc. | Chief Medical Officer | Sell | 6,126 | $78.99 | $483,892.74 | -8.0% | -2.1% | -5.6% |
Page 1Next →